#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Hepatitis B Brain abscess Niemann-Pick disease Blastic plasmacytoid dendritic cell neoplasia Juvenile chronic myelomonocytic leukaemia Undifferentiated sarcoma Fibrosarcoma Factor IX deficiency Meningococcal immunisation Drug eruption Selective polysaccharide antibody deficiency Myotonic dystrophy Optic glioma Microscopic polyangiitis More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Trials in Disease Kearns-Sayre syndrome – Life with Disease Shprintzen-Goldberg syndrome – Treatment Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Ewing’s sarcoma metastatic – Trials in Disease Synovial sarcoma – Trials in Disease Acquired haemophilia – Treatment Netherton’s syndrome – Treatment Mantle cell lymphoma refractory – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    POTASSIUM CLAVULANATE Isoniazid Arachis Hypogaea Extract CLESROVIMAB Art0380 Mesilate Itepekimab Ioflupane (123I) Glipizide Ciclesonide Sertraline Hydrochloride Mesalazine Proguanil Hydrochloride VALACICLOVIR HYDROCHLORIDE Diclofenac Sodium Ulonivirine Betula Alba Pollen Extract Oxygen Ph.eur. Clascoterone Amniotic Membrane, Human IM-101 More therapies…

    Learn about Your Condition

    Alexander disease Type IIa hyperlipidaemia Joint stabilisation Erythema Haemorrhoids Cervix carcinoma stage I Autoimmune disorder Neoplasm malignant Chronic disease Dent's disease Frostbite Loeys-Dietz syndrome Atrophic vulvovaginitis Iron deficiency anaemia Radicular pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Luxembourg

  • Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Carboplatin
    Belgium Czechia France Germany Hungary Italy +2

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany
Previous Page
1 … 4 5 6

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Fluorouracil Carboplatin Paclitaxel Capecitabine Oxaliplatin Folinic Acid Docetaxel Pembrolizumab Prednisolone Acetate Fulvestrant Durvalumab Acetylsalicylic Acid Nivolumab Bevacizumab Prednisone Datopotamab Deruxtecan Olaparib Dexamethasone Prasinezumab Paclitaxel Albumin-Bound Sodium Chloride Irinotecan Hydrochloride Trihydrate Camizestrant Goserelin Abiraterone Acetate Zanidatamab D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala Paracetamol Anastrozole RLY-2608 Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute coronary syndrome Adenocarcinoma gastric Bladder transitional cell carcinoma Breast cancer Breast cancer metastatic Breast cancer stage IV Cervix carcinoma recurrent Chronic coronary syndrome Colon cancer stage II Colon cancer stage III Colorectal cancer metastatic Ductal adenocarcinoma of pancreas Embolism Endometrial cancer Endometrial cancer recurrent Fallopian tube cancer Gastric cancer Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-refractory prostate cancer Lung disorder Malignant peritoneal neoplasm Neoplasm Non-small cell lung cancer Oesophageal adenocarcinoma Oesophageal carcinoma Ovarian cancer Ovarian cancer recurrent Ovarian epithelial cancer Parkinson's disease Prostate cancer Radius fracture Rectal cancer stage II Rectal cancer stage III Small cell lung cancer extensive stage

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!